These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1389901)

  • 21. The role of cytotoxic T-cells in HIV infection.
    Rowland-Jones S; Dong T; Krausa P; Sutton J; Newell H; Ariyoshi K; Gotch F; Sabally S; Corrah T; Kimani J; MacDonald K; Plummer F; Ndinya-Achola J; Whittle H; McMichael A
    Dev Biol Stand; 1998; 92():209-14. PubMed ID: 9554277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mother-to-child transmission of HIV infection and CTL escape through HLA-A2-SLYNTVATL epitope sequence variation.
    Goulder PJ; Pasquier C; Holmes EC; Liang B; Tang Y; Izopet J; Saune K; Rosenberg ES; Burchett SK; McIntosh K; Barnardo M; Bunce M; Walker BD; Brander C; Phillips RE
    Immunol Lett; 2001 Nov; 79(1-2):109-16. PubMed ID: 11595297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors.
    Moss PA; Rowland-Jones SL; Frodsham PM; McAdam S; Giangrande P; McMichael AJ; Bell JI
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5773-7. PubMed ID: 7597028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virus load correlates inversely with the expression of cytotoxic T lymphocyte activation markers in HIV-1-infected/AIDS patients showing MHC-unrestricted CTL-mediated lysis.
    Sindhu ST; Ahmad R; Blagdon M; Ahmad A; Toma E; Morisset R; Menezes J
    Clin Exp Immunol; 2003 Apr; 132(1):120-7. PubMed ID: 12653846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recognition of variant HIV-1 epitopes from diverse viral subtypes by vaccine-induced CTL.
    McKinney DM; Skvoretz R; Livingston BD; Wilson CC; Anders M; Chesnut RW; Sette A; Essex M; Novitsky V; Newman MJ
    J Immunol; 2004 Aug; 173(3):1941-50. PubMed ID: 15265928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis.
    Hadida F; Parrot A; Kieny MP; Sadat-Sowti B; Mayaud C; Debre P; Autran B
    J Clin Invest; 1992 Jan; 89(1):53-60. PubMed ID: 1370302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.
    Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ
    Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxic T-cell recognition of HIV-1 cross-clade and clade-specific epitopes in HIV-1-infected Thai and Japanese patients.
    Fukada K; Tomiyama H; Wasi C; Matsuda T; Kusagawa S; Sato H; Oka S; Takebe Y; Takiguchi M
    AIDS; 2002 Mar; 16(5):701-11. PubMed ID: 11964526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conserved CTL epitopes shared between HIV-infected human long-term survivors and chimpanzees.
    Balla-Jhagjhoorsingh SS; Koopman G; Mooij P; Haaksma TG; Teeuwsen VJ; Bontrop RE; Heeney JL
    J Immunol; 1999 Feb; 162(4):2308-14. PubMed ID: 9973508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CTL ontogeny and viral escape: implications for HIV-1 vaccine design.
    Yang OO
    Trends Immunol; 2004 Mar; 25(3):138-42. PubMed ID: 15036041
    [No Abstract]   [Full Text] [Related]  

  • 31. Relative dominance of epitope-specific cytotoxic T-lymphocyte responses in human immunodeficiency virus type 1-infected persons with shared HLA alleles.
    Day CL; Shea AK; Altfeld MA; Olson DP; Buchbinder SP; Hecht FM; Rosenberg ES; Walker BD; Kalams SA
    J Virol; 2001 Jul; 75(14):6279-91. PubMed ID: 11413294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presence of HLA-C-restricted cytotoxic T-lymphocyte responses in long-term nonprogressors infected with human immunodeficiency virus.
    Nehete PN; Lewis DE; Tang DN; Pollack MS; Sastry KJ
    Viral Immunol; 1998; 11(3):119-29. PubMed ID: 9918403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection.
    McAdam S; Kaleebu P; Krausa P; Goulder P; French N; Collin B; Blanchard T; Whitworth J; McMichael A; Gotch F
    AIDS; 1998 Apr; 12(6):571-9. PubMed ID: 9583596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of a vigorous HIV-1-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex.
    Jassoy C; Johnson RP; Navia BA; Worth J; Walker BD
    J Immunol; 1992 Nov; 149(9):3113-9. PubMed ID: 1383338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Broadly immunogenic HLA class I supertype-restricted elite CTL epitopes recognized in a diverse population infected with different HIV-1 subtypes.
    Pérez CL; Larsen MV; Gustafsson R; Norström MM; Atlas A; Nixon DF; Nielsen M; Lund O; Karlsson AC
    J Immunol; 2008 Apr; 180(7):5092-100. PubMed ID: 18354235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope.
    Safrit JT; Andrews CA; Zhu T; Ho DD; Koup RA
    J Exp Med; 1994 Feb; 179(2):463-72. PubMed ID: 8294860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selection of escape mutant by HLA-C-restricted HIV-1 Pol-specific cytotoxic T lymphocytes carrying strong ability to suppress HIV-1 replication.
    Honda K; Zheng N; Murakoshi H; Hashimoto M; Sakai K; Borghan MA; Chikata T; Koyanagi M; Tamura Y; Gatanaga H; Oka S; Takiguchi M
    Eur J Immunol; 2011 Jan; 41(1):97-106. PubMed ID: 21182081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1.
    Wilson CC; McKinney D; Anders M; MaWhinney S; Forster J; Crimi C; Southwood S; Sette A; Chesnut R; Newman MJ; Livingston BD
    J Immunol; 2003 Nov; 171(10):5611-23. PubMed ID: 14607970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of highly conserved and broadly cross-reactive HIV type 1 cytotoxic T lymphocyte epitopes as candidate immunogens for inclusion in Mycobacterium bovis BCG-vectored HIV vaccines.
    Ferrari G; Kostyu DD; Cox J; Dawson DV; Flores J; Weinhold KJ; Osmanov S
    AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1433-43. PubMed ID: 11018863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CTL response to HIV type 1 subtype C is poorly predicted by known epitope motifs.
    Ngandu NG; Bredell H; Gray CM; Williamson C; Seoighe C;
    AIDS Res Hum Retroviruses; 2007 Aug; 23(8):1033-41. PubMed ID: 17725421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.